Xenex Announces StrikeForce Disinfection Service

LightStrike Robot Destroys COVID-19 Virus in 2 Minutes

June 22, 2020

Xenex notes as cities across Texas report a spike in the number of coronavirus cases, businesses and organizations are looking for strategies to combat the virus within their facilities.

Xenex Disinfection Services, the world leader in UV disinfection for healthcare facilities, today announced the launch of StrikeForce, an innovative disinfection service. For the first time, organizations can engage Xenex’s team of environmental disinfection experts on a project basis to utilize Xenex LightStrike Germ-Zapping Robots to kill harmful viruses, bacteria and spores that linger on commonly touched surfaces and pose a risk for disease transmission. StrikeForce is currently limited to engagements in Texas.

“The entire world is thinking about disease transmission as a result of the COVID-19 pandemic. We had numerous requests from businesses who wanted us to bring robots in and disinfect their facilities for them to help ensure that their environment was virus-free. In response to market demand, we developed the StrikeForce service to enable companies to provide their staff and clients peace of mind through innovative disinfection solutions with minimal downtime,” said Irene Hahn, vice president of sales for Xenex.

The LightStrike disinfection robot is proven to destroy Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, in two minutes. Surfaces contaminated with COVID-19 pose a grave threat to the safety of healthcare workers, patients, frontline responders, military service members, cruise line passengers, hotel guests and citizens everywhere. Deactivating the COVID-19 virus on surfaces is a critical and necessary step to providing a safe environment as businesses reopen and people get back to work. Restaurants, car dealerships, hotels, office buildings, gyms, and many other spaces can benefit immediately from StrikeForce disinfection as the global pandemic demonstrates the need for quick and effective disinfection wherever people work, play, or live.

LightStrike Germ-Zapping Robots use a xenon lamp to generate bursts of high intensity, broad spectrum (200-315nm) ultraviolet (UV) light that’s more intense than sunlight. Different pathogens are susceptible to UVC light at different wavelengths. With broad spectrum germicidal light, Xenex LightStrike robots quickly deactivate viruses, bacteria and spores where they are most vulnerable without damaging materials or equipment.

Xenex is the world leader in UV disinfection for healthcare facilities and its LightStrike robots have been deployed in more than 500 healthcare facilities around the world, including HonorHealth, the Mayo Clinic, MD Anderson Cancer Center, Stanford, and USC. The robots work quickly and do not require warm-up or cool-down time, so facilities are able to disinfect dozens of rooms per day (per robot). Hospitals have published peer-reviewed studies showing significant reductions in Clostridium difficile (C.diff), MRSA, VRE and/or Surgical Site Infection (SSI) rates after integrating Xenex’s infection prevention programs and using LightStrike robots to supplement their environmental disinfection efforts.

SourceXenex

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”